Back to Journals » Drug Design, Development and Therapy » Volume 13

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]

Authors Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK

Received 16 May 2019

Accepted for publication 16 May 2019

Published 24 May 2019 Volume 2019:13 Pages 1819—1820

DOI https://doi.org/10.2147/DDDT.S215949


Mu M, Zuo S, Wu RM, et al. Drug Des Devel Ther. 2018;12:4107–4115.

An error has been found in a couple of the image labels for Figure 3F. On page 4112, the original Figure 3F image appears as:
 
Read the original article:

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]